AGEN: Antigenics Cancer Drug Gets Russia OK

Just Speculating on this one. Quite the upside potential. Its a tiny biotech company with a market cap of 175.98M. It just won approval to market its kidney cancer vaccine, Oncophage, in Russia, making it the only cancer vaccine available in the world. The product was approved despite failing to win approval in the United States. It is the first time the Russian government has approved a foreign drug that was not first cleared in its country of origin, Antigenics said. Antigenics is also planning to file for approval of the vaccine in Europe by the end of the year.